Senior Leadership Team

QPS’ Senior Leadership Team (SLT) is collectively responsible for the global success of QPS. With representation from each of the global business functions and each of the global business sites, their primary responsibilities include exercising independent and objective judgement, as well as providing constructive challenges to local management teams to ensure the highest possible performance.

In addition, this team is responsible for setting strategy, developing policy, and monitoring progress towards meeting our annual goals and objectives. Our CEO, Dr. Ben Chien, leads the SLT, acts as the primary liaison to the Board of Directors, and has accountability for the annual performance of the global business. Dr. Chien also leads the SLT team through regular business performance reviews and challenges the team’s strategic thinking to improve results.

Ben Chien, Ph.D.

Chairman, President and Chief Executive Officer

Ben Hsu, Ph.D. MBA

Chief Administrative Officer and General Manager, QPS LLC

Brendon Bourg

VP, General Manager, Missouri

Camille Picq, MBA

Senior Director,
Head of Lab Services Business Development, Europe

Charlene Chen

Deputy General Manager and Head of CTPS, QPS Taiwan

ChauHwei Fu, Ph.D.

VP, Global Head of Clinical Research Services

Dawn Moore

Executive Director,
Head of Lab Services Business Development, US

Edwin van Vulpen

Executive Director and Head of Clinical Business Development Europe

Gabrielle Pastore

VP, Global Head of Marketing

John Kolman, Ph.D.

VP, Global Head, Translational Medicine

John Musante, MBA

EVP & Head of Global Clinical Services

Jose L. Marcos, CCRC, MT

Executive Director, Clinical Operations

Judy Morris

Director & Head of Global HR

Kevin Vernarec

Sr. VP, Global Head of Late Phase Clinical Development

Kimberley Buytaert-Hoefen, Ph.D.

Executive Director and Global Head of Regulatory Affairs

Kumar Ramu, Ph.D.

Sr. VP, General Manager, India

Manuela Prokesch, Ph.D.

Director of Neuropharmacology

Pedro Gonzalez

VP of Finance

Robert Wronski, Ph.D.

Sr. Director, Head of EU Late Phase Clinical Development

Sarah Cross, Ph.D.

Executive Director & Head of Global Medical Affairs

Vincent Yen, MBA

Regional General Manager, Asia

Wendy Finan

Director, Global Head of Quality Assurance

Wim Tamminga, Ph.D.

Sr. VP, Global Head of Early Phase Clinical

Zamas Lam, Ph.D.

Sr. VP, Global Head, Bioanalytical and Global Head, Preclinical Development

QPS’ Business Development Team is collectively responsible for building strong relationships with existing and potential customers and generating business opportunities for QPS.

Through these relationships, the team shares comprehensive information about the global capabilities of QPS across Bioanalysis, Clinical Research Services, Dermal and Transdermal Research, DMPK, Neuropharmacology, Translational Medicine, Toxicology, as well as Early and Late Phase Clinical Trials. With team alignment across each of the global business functions and each of the global business sites, their primary responsibilities include understanding the specific needs of each individual customer and providing custom-built research service proposals to meet their very specific requirements.

Business development responsibilities are divided across 2 teams, both led by industry veterans, Zamas Lam, Ph.D., Sr. VP, Global Head, Bioanalytical and Global Head, Preclinical Development, and John Musante, Sr. VP, Global Head of Clinical Business Development. Please feel free to contact the QPS Business Development Team by email at [email protected], or look for us at an upcoming Conference. We look forward to the opportunity to custom-build your next clinical research solution.

Preclinical Business Development

Camille Picq, MBA

Senior Director,
Head of Lab Services Business Development, Europe

Dawn Moore

Executive Director,
Head of Lab Services Business Development, US

John Katiforis

Director

Joy Concepcion

Director

Mark Warren

Director

Early & Late Phase Clinical Business Development

John Musante, MBA

EVP & Head of Global Clinical Services

Edwin van Vulpen

Executive Director and Head of Clinical Business Development Europe

Andrew Nehls, MS

Sr. Director

Benjamin Abrams

Director

Darlene Colon, MBA

Director

Jim Cunningham

Executive Director

Jonathan Quinn

Director

Mark McDonald

Sr. Director

Maria Lundius

Director

Robert Cathell

Associate Director, Clinical Business Development

Global Business Development

Alex Chang

VP, Sales and Marketing, Asia

Andrew Lin

Sr. Manager, Taiwan

Bhavya Latha Thirunagari

Manager, India

Chen Huang

Director, Taiwan

Doris Chi

Sr. Manager, China

Ewald Auer, MSc.

Director, Neuropharmacology

Joelle Kasbo

Sr. Director

Matisse Liu

Manager, NKSP, Taiwan

Nick Vrentzos M.Sc.

Sr. Director, India

Roland Rabl

Manager, Neuropharmacology

Stefanie Krassnig, Ph.D.

Manager, Neuropharmacology

Tracy Tsai

Assistant Manager, Taiwan

Vera Niederkofler, Ph.D.

Manager, Neuropharmacology

V.V.S Shiva Prasad, Ph.D.

Chief Operating Officer, India

QPS’ Primary Investigator Team is composed of dedicated physicians, supported by an extensive network of supplementary specialist physicians, who ensure consistent high-level study oversight from the early study planning stages through to study completion. Every QPS clinical trial site, across the USA, Europe, Taiwan and India, has a team of dedicated physicians to ensure that each clinical trial is run seamlessly. This highly experienced team maintains regular communication with the sponsor partners throughout the clinical trial process. We appreciate that working closely with the sponsor will yield the most efficient and successful trial.

The QPS Primary Investigator Team’s core responsibilities span the entire range of clinical trial activities, from early stage proposal development, to study design and ultimately, healthy volunteer and/or patient care.